Palleon Pharmaceuticals
PrivateLast Round
Series B
Sep 17, 2020
Est. Valuation
$238.83M
Total Funding Raised
$147.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Palleon Pharmaceuticals is a biotechnology company that develops glyco-immunology therapeutics to treat cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Palleon Pharmaceuticals Comparables
Compare Palleon Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoC4, Inc. | 81% | |
| Valora Therapeutics Inc. | 79% | |
| Tacalyx | 77% |
Palleon Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 17, 2020 | ||||
| Series A | Oct 4, 2017 |
Key People
Founding team and executive leadership
Palleon Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series B |
| Vertex Ventures HC | Series A, Series B |
| AbbVie Ventures | Series A, Series B |
| Citadel | Series B |
| Matrix Capital Management | Series B |
| Pfizer Ventures | Series B, Series A |
| Takeda Ventures | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 79% MoM, reaching 5K.
- Apr 20, 2026
Presented B7-H3 Targeted Sialidase at the 2026 AACR Annual Meeting.
Palleon Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Palleon Pharmaceuticals's valuation, stock price, and market status.
Is Palleon Pharma a public or private company?
Palleon Pharma is a private company.
What is the current stock price of Palleon Pharma?
Palleon Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is Palleon Pharma worth (valuation)?
Palleon Pharma's valuation is estimated at $238.8M based on funding round data.
Can I buy Palleon Pharma stock?
Palleon Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Palleon Pharma's last funding round?
Palleon Pharma's most recent funding round was Series B on September 17, 2020.
Who are the main investors in Palleon Pharma?
Key investors in Palleon Pharma include Matrix Capital Management, Pfizer Ventures, SR One.
Will Palleon Pharma IPO soon?
No public IPO plans have been announced for Palleon Pharma.
How can I track Palleon Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Palleon Pharma's secondary market activity and sign up for updates.